The novel triterpenoid C-28 methyl ester of 2-cyano-3, 12-dioxoolen-1, 9-dien-28-oic acid inhibits metastatic murine breast tumor growth through inactivation of STAT3 signaling.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Cancer Research

• Publication date

  2007-05-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1158/0008-5472.CAN-06-3629PMID 17483332
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Synthetic triterpenoid 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid induces growth arrest in HER2-overexpressing breast cancer cells

  2006cited by this paper
• A synthetic triterpenoid, CDDO-Me, inhibits IkappaBalpha kinase and enhances apoptosis induced by TNF and chemotherapeutic agents through down-regulation of expression of nuclear factor kappaB-regulated gene products in human leukemic cells.

  2006cited by this paper
• Activation of Stat3 in Primary Tumors from High-Risk Breast Cancer Patients Is Associated with Elevated Levels of Activated Src and Survivin Expression

  2006cited by this paper
• Mechanisms of apoptosis sensitivity and resistance to the BH3 mimetic ABT-737 in acute myeloid leukemia.

  2006cited by this paper
• A Synthetic Triterpenoid, CDDO-Me, Inhibits IκBα Kinase and Enhances Apoptosis Induced by TNF and Chemotherapeutic Agents through Down-Regulation of Expression of Nuclear Factor κB–Regulated Gene Products in Human Leukemic Cells

  2006cited by this paper
• Matrix metalloproteinases and tumor metastasis

  2006cited by this paper
• Activation of Dendritic Cells via Inhibition of Jak2/STAT3 Signaling1

  2005cited by this paper
• Exploiting the PI3K/AKT Pathway for Cancer Drug Discovery

  2005cited by this paper
• Wnt, Hedgehog, and Snail: Sister Pathways That Control by GSK-3beta and beta-Trcp in the Regulation of Metastasis

  2005cited by this paper
• Knockdown of STAT3 expression by RNA interference inhibits the induction of breast tumors in immunocompetent mice.

  2005influential reference
• 2-Cyano-3,12-dioxoolean-1,9-dien-28-oic Acid and Related Compounds Inhibit Growth of Colon Cancer Cells through Peroxisome Proliferator-Activated Receptor γ-Dependent and -Independent Pathways

  2005cited by this paper
• The STAT3 Transcription Factor Is a Target for the Myc and Riboblastoma Proteins on the Cdc25A Promoter*

  2005cited by this paper
• c-Jun NH2-Terminal Kinase-Mediated Up-regulation of Death Receptor 5 Contributes to Induction of Apoptosis by the Novel Synthetic Triterpenoid Methyl-2-Cyano-3,12-Dioxooleana-1, 9-Dien-28-Oate in Human Lung Cancer Cells

  2004cited by this paper
• Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells

  2004cited by this paper
• MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer

  2004cited by this paper
• Role of STATs as downstream signal transducers in Src family kinase-mediated tumorigenesis

  2004cited by this paper
• Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis.

  2004cited by this paper
• Combination of local, nonviral IL12 gene therapy and systemic paclitaxel treatment in a metastatic breast cancer model.

  2004cited by this paper
• IL-6 Regulates In Vivo Dendritic Cell Differentiation through STAT3 Activation1

  2004cited by this paper
• Bcr and Abl interaction: oncogenic activation of c-Abl by sequestering Bcr.

  2003cited by this paper
• A critical role for Stat3 signaling in immune tolerance.

  2003cited by this paper
• Activation of peroxisome proliferator-activated receptor gamma by a novel synthetic triterpenoid 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid induces growth arrest and apoptosis in breast cancer cells.

  2003cited by this paper
• Series Introduction: JAK-STAT signaling in human disease

  2002cited by this paper
• Novel triterpenoid CDDO-Me is a potent inducer of apoptosis and differentiation in acute myelogenous leukemia.

  2002cited by this paper
• DNA Recognition by NFκB and STAT Transcription Factors

  2001cited by this paper
• Phosphorylation of Bcl2 and regulation of apoptosis

  2001cited by this paper
• DNA recognition by NF kappa B and STAT transcription factors.

  2001cited by this paper
• Stat3-mediated Myc expression is required for Src transformation and PDGF-induced mitogenesis

  2001cited by this paper
• STATs in oncogenesis

  2000cited by this paper
• Cooperativity of Staphylococcal aureus enterotoxin B superantigen, major histocompatibility complex class II, and CD80 for immunotherapy of advanced spontaneous metastases in a clinically relevant postoperative mouse breast cancer model.

  2000cited by this paper
• Overexpression of ErbB2 blocks Taxol-induced apoptosis by upregulation of p21Cip1, which inhibits p34Cdc2 kinase.

  1998cited by this paper
• Reduction of established spontaneous mammary carcinoma metastases following immunotherapy with major histocompatibility complex class II and B7.1 cell-based tumor vaccines.

  1998cited by this paper
• Constitutive activation of Stat3 in fibroblasts transformed by diverse oncoproteins and in breast carcinoma cells.

  1997cited by this paper
• Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumor.

  1992cited by this paper

• Bardoxolone Methyl: A Comprehensive Review of Its Role as a Nrf2 Activator in Anticancer Therapeutic Applications

  2025cites this paper
• PJA1-mediated suppression of pyroptosis as a driver of docetaxel resistance in nasopharyngeal carcinoma

  2024cites this paper
• Recent advances in medicinal chemistry of oleanolic acid derivatives.

  2022cites this paper
• CDDO-Me Attenuates Astroglial Autophagy via Nrf2-, ERK1/2-SP1- and Src-CK2-PTEN-PI3K/AKT-Mediated Signaling Pathways in the Hippocampus of Chronic Epilepsy Rats

  2021cites this paper
• The Match between Molecular Subtypes, Histology and Microenvironment of Pancreatic Cancer and Its Relevance for Chemoresistance

  2021cites this paper
• The role of natural products in revealing NRF2 function.

  2020cites this paper
• Cyano Enone-Bearing Triterpenoid Soloxolone Methyl Inhibits Epithelial-Mesenchymal Transition of Human Lung Adenocarcinoma Cells In Vitro and Metastasis of Murine Melanoma In Vivo

  2020cites this paper
• CDDO-Me Distinctly Regulates Regional Specific Astroglial Responses to Status Epilepticus via ERK1/2-Nrf2, PTEN-PI3K-AKT and NFκB Signaling Pathways

  2020cites this paper
• Synthetic Triterpenoid CDDO-Me Inhibits Proliferation, Migration, and Invasion in GBM8401 and GBM8901

  2020cites this paper
• Myeloid-Derived Suppressor Cells and Pancreatic Cancer: Implications in Novel Therapeutic Approaches

  2019cites this paper
• New substituted quinoxalines inhibit triple-negative breast cancer by specifically downregulating the c-MYC transcription

  2019cites this paper
• Pharmacological Augmentation of Heavy Ion Cancer Therapy

  2018cites this paper
• Bardoxolone methyl for the prevention of obesity focusing on the pathology of gut-brain-adipose axis

  2017influential citation
• Bardoxolone methyl (CDDO-Me or RTA402) induces cell cycle arrest, apoptosis and autophagy via PI3K/Akt/mTOR and p38 MAPK/Erk1/2 signaling pathways in K562 cells.

  2017cites this paper
• Modulation of Tumour-Related Signaling Pathways by Natural Pentacyclic Triterpenoids and their Semisynthetic Derivatives.

  2017cites this paper
• Combined targeting of STAT3 and STAT5: a novel approach to overcome drug resistance in chronic myeloid leukemia

  2017cites this paper
• Anticancer effect of SZC017, a novel derivative of oleanolic acid, on human gastric cancer cells.

  2016cites this paper
• A novel small molecule STAT3 inhibitor, LY5, inhibits cell viability, colony formation, and migration of colon and liver cancer cells

  2016cites this paper
• RTA 408, A Novel Synthetic Triterpenoid with Broad Anticancer and Anti-Inflammatory Activity

  2015cites this paper
• Bardoxolone methyl induces apoptosis and autophagy and inhibits epithelial-to-mesenchymal transition and stemness in esophageal squamous cancer cells

  2015cites this paper
• A Review: Phytochemicals Targeting JAK/STAT Signaling and IDO Expression in Cancer

  2015cites this paper
• Cancer Cell Growth Is Differentially Affected by Constitutive Activation of NRF2 by KEAP1 Deletion and Pharmacological Activation of NRF2 by the Synthetic Triterpenoid, RTA 405

  2015cites this paper
• Myeloid-derived suppressor cells: their role in the pathophysiology of hematologic malignancies and potential as therapeutic targets

  2015cites this paper
• Can a plant-derived compound provide a lupus lifeline?

  2015cites this paper
• Anticancer effect of SZC 017 , a novel derivative of oleanolic acid , on human gastric cancer cells

  2015cites this paper
• CDDO-Me inhibits tumor growth and prevents recurrence of pancreatic ductal adenocarcinoma

  2015cites this paper
• Induction of Apoptosis in Pancreatic Cancer Cells by CDDO-Me Involves Repression of Telomerase through Epigenetic Pathways

  2014cites this paper
• Oleanolic acid and its synthetic derivatives for the prevention and therapy of cancer: preclinical and clinical evidence.

  2014cites this paper
• Preclinical evidences toward the use of triterpenoid CDDO-Me for solid cancer prevention and treatment

  2014cites this paper
• Oleanane triterpenoids in the prevention and therapy of breast cancer: current evidence and future perspectives

  2014influential citation
• Activation of STAT3 is involved in malignancy mediated by CXCL12-CXCR4 signaling in human breast cancer.

  2014cites this paper
• The Acetylenic Tricyclic Bis(cyano enone), TBE-31 Inhibits Non–Small Cell Lung Cancer Cell Migration through Direct Binding with Actin

  2014cites this paper
• Bardoxolone methyl (BARD) ameliorates aristolochic acid (AA)-induced acute kidney injury through Nrf2 pathway.

  2014cites this paper
• Oxaliplatin activates the Keap1/Nrf2 antioxidant system conferring protection against the cytotoxicity of anticancer drugs.

  2014cites this paper
• Prevention of Murine Lupus Nephritis by Targeting Multiple Signaling Axes and Oxidative Stress Using a Synthetic Triterpenoid

  2014cites this paper
• Activation of STAT 3 is involved in malignancy mediated by CXCL 12-CXCR 4 signaling in human breast cancer

  2014cites this paper
• The CXCR4 Antagonist AMD3465 Regulates Oncogenic Signaling and Invasiveness In Vitro and Prevents Breast Cancer Growth and Metastasis In Vivo

  2013influential citation
• Chemopreventive effect of a novel oleanane triterpenoid in a chemically induced rodent model of breast cancer

  2013cites this paper
• A synthetic PPAR-γ agonist triterpenoid ameliorates experimental fibrosis: PPAR-γ-independent suppression of fibrotic responses

  2013cites this paper
• Suppression of Mammary Tumorigenesis by a Gemini Vitamin D Analog and a Synthetic Triterpenoid

  2013cites this paper
• Honokiol analogs: a novel class of anticancer agents targeting cell signaling pathways and other bioactivities.

  2013cites this paper
• Nrf2 acts cell-autonomously in endothelium to regulate tip cell formation and vascular branching

  2013cites this paper
• The potential effect of triterpenoids in triple negative breast cancer

  2013cites this paper
• Prevention of Obesity, Diabetes, and Cancer with Lifestyle Intervention Strategies

  2012cites this paper
• Synthetic Oleanane Triterpenoids: Multifunctional Drugs with a Broad Range of Applications for Prevention and Treatment of Chronic Disease

  2012influential citation
• MRx102, a triptolide derivative, has potent antileukemic activity in vitro and in a murine model of AML

  2012cites this paper
• A Phase I First-in-Human Trial of Bardoxolone Methyl in Patients with Advanced Solid Tumors and Lymphomas

  2012cites this paper
• Small molecule inhibitors of signal transducer and activator of transcription 3 (Stat3) protein.

  2012cites this paper
• Disparate Impact of Butyroyloxymethyl Diethylphosphate (AN-7), a Histone Deacetylase Inhibitor, and Doxorubicin in Mice Bearing a Mammary Tumor

  2012cites this paper
• Inhibition of cell proliferation and induction of apoptosis by oleanane triterpenoid (CDDO-Me) in pancreatic cancer cells is associated with the suppression of hTERT gene expression and its telomerase activity.

  2012cites this paper
• Triterpenoids for cancer prevention and treatment: current status and future prospects.

  2012cites this paper
• Oleanane triterpenoid CDDO-Me inhibits Akt activity without affecting PDK1 kinase or PP2A phosphatase activity in cancer cells.

  2012cites this paper
• Bardoxolone methyl (BARD) ameliorates ischemic AKI and increases expression of protective genes Nrf2, PPARγ, and HO-1.

  2011cites this paper
• New Mechanism Based Anticancer Drugs for Treatment of Pancreatic and Bladder Cancers

  2011cites this paper
• New Synthetic Triterpenoids: Potent Agents for Prevention and Treatment of Tissue Injury Caused by Inflammatory and Oxidative Stress

  2011cites this paper
• Oleanolic acid derivative Dex-OA has potent anti-tumor and anti-metastatic activity on osteosarcoma cells in vitro and in vivo

  2011cites this paper
• Triterpenoids as potential agents for the chemoprevention and therapy of breast cancer.

  2011cites this paper
• Protection against 2-chloroethyl ethyl sulfide (CEES)-induced cytotoxicity in human keratinocytes by an inducer of the glutathione detoxification pathway.

  2011cites this paper
• Role of reactive oxygen species (ROS) in CDDO-Me-mediated growth inhibition and apoptosis in colorectal cancer cells.

  2011cites this paper
• Prevention of Prostate Cancer with Oleanane Synthetic Triterpenoid CDDO-Me in the TRAMP Mouse Model of Prostate Cancer

  2011cites this paper
• MRI to assess chemoprevention in transgenic adenocarcinoma of mouse prostate (TRAMP)

  2011cites this paper
• Synthetic triterpenoid CDDO prevents the progression and metastasis of prostate cancer in TRAMP mice by inhibiting survival signaling.

  2011cites this paper
• Anti-inflammatory Triterpenoid Blocks Immune Suppressive Function of MDSCs and Improves Immune Response in Cancer

  2010cites this paper
• Mesenchymal Stem Cells Overexpressing IFN-β Inhibit Breast Cancer Growth and Metastases through Stat3 Signaling in a Syngeneic Tumor Model

  2010influential citation
• Synthetic triterpenoids inhibit growth, induce apoptosis and suppress pro-survival Akt, mTOR and NF-{kappa}B signaling proteins in colorectal cancer cells.

  2010cites this paper
• The Triterpenoid 2-Cyano-3,12-dioxooleana-1,9-dien-28-oic-acid Methyl Ester Has Potent Anti-diabetic Effects in Diet-induced Diabetic Mice and Leprdb/db Mice*

  2010cites this paper
• Mesenchymal stromal cells alone or expressing interferon-beta suppress pancreatic tumors in vivo, an effect countered by anti-inflammatory treatment.

  2010cites this paper
• Anticancer Role of PPARγ Agonists in Hematological Malignancies Found in the Vasculature, Marrow, and Eyes

  2010cites this paper
• Oleanane triterpenoid CDDO-Me inhibits growth and induces apoptosis in prostate cancer cells through a ROS-dependent mechanism.

  2010cites this paper
• Synthetic Triterpenoids Target the Arp2/3 Complex and Inhibit Branched Actin Polymerization*

  2010cites this paper
• Emerging anticancer therapeutic targets and the cardiovascular system: is there cause for concern?

  2010cites this paper
• Blockage of Stat3 With CDDO-Me Inhibits Tumor Cell Growth in Chordoma

  2010influential citation
• Dendritic cells in cancer

  2009cites this paper
• Signal Transducer and Activator of Transcription‐3, Inflammation, and Cancer

  2009cites this paper
• Triterpenoids as new promising anticancer drugs.

  2009cites this paper
• Induction of apoptosis and nonsteroidal anti‐inflammatory drug‐activated gene 1 in pancreatic cancer cells by a glycyrrhetinic acid derivative

  2009cites this paper
• Oleanane Triterpenoid CDDO‐Me inhibits growth and induces apoptosis in prostate cancer cells by independently targeting pro‐survival Akt and mTOR

  2009cites this paper
• Direct Evidence of Mesenchymal Stem Cell Tropism for Tumor and Wounding Microenvironments Using In Vivo Bioluminescent Imaging

  2009cites this paper
• Terpenoids and breast cancer chemoprevention

  2009cites this paper
• Synthetic triterpenoids attenuate cytotoxic retinal injury: cross-talk between Nrf2 and PI3K/AKT signaling through inhibition of the lipid phosphatase PTEN.

  2009cites this paper
• A Role for STAT3 in Dendritic Cell Regulation by Tumor-Derived Factors

  2009cites this paper
• First-in-class, first-in-human phase I results of targeted agents: Highlights of the 2008 American Society of Clinical Oncology meeting

  2008cites this paper
• Apoptotic activity and mechanism of 2-cyano-3,12-dioxoolean-1,9-dien-28-oic-acid and related synthetic triterpenoids in prostate cancer.

  2008cites this paper
• Triterpenoid CDDO-methyl ester inhibits the Janus-activated kinase-1 (JAK1)-->signal transducer and activator of transcription-3 (STAT3) pathway by direct inhibition of JAK1 and STAT3.

  2008cites this paper
• Mutant FLT3: a direct target of sorafenib in acute myelogenous leukemia.

  2008cites this paper
• Coupling of endoplasmic reticulum stress to CDDO-Me-induced up-regulation of death receptor 5 via a CHOP-dependent mechanism involving JNK activation.

  2008cites this paper
• Mutant FLT 3 : A Direct Target of Sorafenib in Acute Myelogenous Leukemia

  2008cites this paper
• Immunomodulatory Activity of Synthetic Triterpenoids: Inhibition of Lymphocyte Proliferation, Cell-Mediated Cytotoxicity, and Cytokine Gene Expression Through Suppression of NF-κB

  2008cites this paper
• Platforms and networks in triterpenoid pharmacology

  2007cites this paper
• The synthetic oleanane triterpenoid, CDDO-methyl ester, is a potent antiangiogenic agent

  2007cites this paper
• The synthetic triterpenoid CDDO-Imidazolide suppresses experimental liver metastasis

  2007influential citation